NGM·Healthcare·$498M·#237 / 520 in Healthcare

XOMA XOMA Royalty Corporation

47SPECULATIVE

CATEGORY BREAKDOWN

GROWTH23
QUALITY40
STABILITY67
VALUATION47
GOVERNANCE53

METRIC BREAKDOWN

Revenue Growth (YoY)

Year-over-year revenue growth rate

+14.1%
23

> 50% strong

Gross Margin

Revenue retained after direct costs

N/A
0

> 50% strong

Cash Runway

Months of cash at current burn rate

999 months
100

> 24 months ideal

Debt / Equity

Total debt relative to shareholder equity

156.7%
0

< 25% strong

Price / Sales

Market cap relative to trailing revenue

9.5x
47

< 3x strong

Rule of 40

Growth rate plus operating margin

112
100

> 40 excellent

Insider Ownership

Percentage of shares held by insiders

4.2%
33

> 20% strong

Share Dilution (12M)

Share count increase over last 12 months

+1.5%
91

< 5% ideal

SCORE HISTORY

COMPARE XOMA WITH…

XOMAvs

OR QUICK-COMPARE SECTOR PEERS

SCORE ALERT

Get notified when XOMA's score changes by 5+ points.

DATA INFO

Last updated: May 4, 2026

Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.